Depreciation in USD of IOVANCE BIOTHERAPEUTICS, INC. from 2013 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Iovance Biotherapeutics, Inc. quarterly/annual Depreciation history and change rate from 2013 to Q1 2023.
  • Iovance Biotherapeutics, Inc. Depreciation for the quarter ending March 31, 2023 was $2.8M, a 55.6% increase year-over-year.
  • Iovance Biotherapeutics, Inc. Depreciation for the twelve months ending March 31, 2023 was $10.3M, a 129% increase year-over-year.
  • Iovance Biotherapeutics, Inc. annual Depreciation for 2022 was $9.3M, a 200% increase from 2021.
  • Iovance Biotherapeutics, Inc. annual Depreciation for 2021 was $3.1M, a 182% increase from 2020.
  • Iovance Biotherapeutics, Inc. annual Depreciation for 2020 was $1.1M, a 8.33% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

IOVANCE BIOTHERAPEUTICS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $10.3M $2.8M +$1M +55.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $9.3M $2.8M +$1.4M +100% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-28
Q3 2022 $7.9M $2.5M +$1.5M +150% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $6.4M $2.2M +$1.9M +633% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $4.5M $1.8M +$1.4M +350% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $3.1M $1.4M +$1.1M +367% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $2M $1M +$700K +233% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.3M $300K +$100K +50% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.2M $400K +$100K +33.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.1M $300K Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $300K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $200K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $300K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2015 $266K +$261K +5220% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-06
Q3 2014 $5K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06

IOVANCE BIOTHERAPEUTICS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $9.3M +$6.2M +200% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-28
2021 $3.1M +$2M +182% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $1.1M -$100K -8.33% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $1.2M +$200K +20% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $1M $0 0% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $1M $0 0% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $1M $0 0% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $1M +$900K +900% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $100K +$93K +1329% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 $7K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.